CVE-2023-44487
Published: October 10, 2023
Official Description
HTTP/2 contains a rapid reset vulnerability that allows for a distributed denial-of-service attack (DDoS).
CISA KEV Advisory
HTTP/2 Rapid Reset Attack Vulnerability
HTTP/2 contains a rapid reset vulnerability that allows for a distributed denial-of-service attack (DDoS).
Apply mitigations per vendor instructions, follow applicable BOD 22-01 guidance for cloud services, or discontinue use of the product if mitigations are unavailable.
Risk Analysis
This HTTP/2 rapid reset vulnerability enables distributed denial-of-service (DDoS) attacks, potentially disrupting service availability. The very high EPSS score indicates a strong likelihood of exploitation, and its inclusion in CISA's KEV confirms active exploitation, making this a critical and urgent issue.
Active exploitation of this vulnerability has been observed in the wild, indicating that working exploits are readily available and being used by attackers. This flaw is remotely exploitable.
Implement HTTP/2 rapid reset attack mitigations at the network edge, such as rate limiting and connection management. Ensure all web servers and proxies are updated to versions that address this vulnerability.
Technical Analysis
CVE-2023-44487 requires local access, meaning attackers must already have a foothold on the target system.
Exploitation requires some privileges, which limits the exposure to scenarios where an attacker has already gained initial access.
CISA has added CVE-2023-44487 to the Known Exploited Vulnerabilities (KEV) catalog, confirming active exploitation in the wild. U.S. federal agencies are required to patch this within the mandated timeframe, and all organizations should treat remediation as urgent.
Exploit & PoC Resources
All References (2)
Quick Facts
Recommended Actions
- →Apply vendor patches immediately
- →Monitor CVE-2023-44487 in threat intel feeds
- →Review IDS/IPS signatures for exploitation attempts
- !CISA KEV: Federal agencies must patch per BOD 22-01 timeline
- !Active exploitation confirmed — treat as P1